Tandem Diabetes Care Inc (Tandem) is a medical device manufacturing company that designs and develops diabetic care products. The company's product portfolio includes X2 insulin pump, basal-IQ technology, Control-IQ technology, software and applications, infusion sets and other pump accessories. In addition, it also offers connected health offerings. Tandem also provides product support services helping its clients to further customize their systems. The company distributes its products across various regions including Canada, Australia, New Zealand, Saudi Arabia and South Africa. Tandem is headquartered in San Diego, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Tandem Diabetes Care Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Tandem Diabetes Care Inc Company Overview
- Tandem Diabetes Care Inc Company Snapshot
- Tandem Diabetes Care Inc Pipeline Products and Ongoing Clinical Trials Overview
- Tandem Diabetes Care Inc - Pipeline Analysis Overview
- Tandem Diabetes Care Inc - Key Facts
- Tandem Diabetes Care Inc - Major Products and Services
- Tandem Diabetes Care Inc Pipeline Products by Development Stage
- Tandem Diabetes Care Inc Ongoing Clinical Trials by Trial Status
- Tandem Diabetes Care Inc Pipeline Products Overview
- Control-IQ
- Product Status
- CSII Catheter
- CSII Catheter Product Overview
- CSII Catheter Clinical Trial
- Next Generation Closed Loop
- Next Generation Closed Loop Product Overview
- Next Generation Gswim
- Next Generation Gswim Product Overview
- Sigi Patch Pump
- Sigi Patch Pump Product Overview
- Sigi Patch Pump Clinical Trial
- SteadiSet Infusion Set
- SteadiSet Infusion Set Product Overview
- SteadiSet Infusion Set Clinical Trial
- t:connect Mobile - Biometric Authentication
- t:connect Mobile - Biometric Authentication Product Overview
- t:connect Mobile - Decision Support
- t:connect Mobile - Decision Support Product Overview
- t:connect Mobile - Health App Integration
- t:connect Mobile - Health App Integration Product Overview
- t:slim X2 Control-IQ System Integrated with Dexcom G7 CGM
- t:slim X2 Control-IQ System Integrated with Dexcom G7 CGM Product Overview
- t:slim X3 Insulin Pump
- t:slim X3 Insulin Pump Product Overview
- Tandem Mobi Insulin Pump With Interoperable Technology
- Tandem Mobi Insulin Pump With Interoperable Technology Product Overview
- Tandem Mobi: Tubeless
- Tandem Mobi: Tubeless Product Overview
- Tandem Patch
- Tandem Patch Product Overview
- Tandem Diabetes Care Inc - Key Competitors
- Tandem Diabetes Care Inc - Key Employees
- Tandem Diabetes Care Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Tandem Diabetes Care Inc, Recent Developments
- Jan 19, 2023: Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2022 Financial Results on February 22, 2023
- Aug 22, 2022: Tandem Diabetes Care Announces Upcoming Conference Presentations
- Jul 12, 2022: Tandem Diabetes Care to Announce Second Quarter 2022 Financial Results on August 3 2022
- May 04, 2022: Tandem Diabetes Care Announces First Quarter 2022 Financial Results and Updated Full Year 2022 Financial Guidance
- Dec 02, 2021: Tandem Diabetes Care Announces Expansion of Senior Leadership Team
- Nov 18, 2021: Tandem Diabetes Care to Participate in the 33rd Annual Piper Sandler Virtual Healthcare Conference
- Nov 03, 2021: Tandem Diabetes Care Announces Third Quarter 2021 Financial Results and Updated Full Year 2021 Sales Guidance
- Oct 07, 2021: Tandem Diabetes Care to Announce Third Quarter 2021 Financial Results on November 3, 2021
- Jul 29, 2021: Tandem Diabetes Care Announces Upcoming Conference Presentation
- Jul 12, 2021: Tandem Diabetes Care to Announce Second Quarter 2021 Financial Results on August 4, 2021
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Tandem Diabetes Care Inc Pipeline Products and Ongoing Clinical Trials Overview
- Tandem Diabetes Care Inc Pipeline Products by Equipment Type
- Tandem Diabetes Care Inc Pipeline Products by Indication
- Tandem Diabetes Care Inc Ongoing Clinical Trials by Trial Status
- Tandem Diabetes Care Inc, Key Facts
- Tandem Diabetes Care Inc, Major Products and Services
- Tandem Diabetes Care Inc Number of Pipeline Products by Development Stage
- Tandem Diabetes Care Inc Pipeline Products Summary by Development Stage
- Tandem Diabetes Care Inc Ongoing Clinical Trials by Trial Status
- Tandem Diabetes Care Inc Ongoing Clinical Trials Summary
- Product Status
- Control-IQ - Product Description
- CSII Catheter - Product Status
- CSII Catheter - Product Description
- CSII Catheter - A Pilot Study for the Systematic Evaluation of the Inflammatory Response to Commercially Available Insulin Infusion Catheters in Subcutaneous Adipose Tissue
- Next Generation Closed Loop - Product Status
- Next Generation Closed Loop - Product Description
- Next Generation Gswim - Product Status
- Next Generation Gswim - Product Description
- Sigi Patch Pump - Product Status
- Sigi Patch Pump - Product Description
- Sigi Patch Pump - Sigi Insulin Management System - First-in-Human Study
- SteadiSet Infusion Set - Product Status
- SteadiSet Infusion Set - Product Description
- SteadiSet Infusion Set - A Pivotal, Non-randomized, Prospective and Single Arm Study to Evaluate SteadiFlow Seven-day-wear Infusion Set Technology in Type I Diabetes Subjects
- t:connect Mobile - Biometric Authentication - Product Status
- t:connect Mobile - Biometric Authentication - Product Description
- t:connect Mobile - Decision Support - Product Status
- t:connect Mobile - Decision Support - Product Description
- t:connect Mobile - Health App Integration - Product Status
- t:connect Mobile - Health App Integration - Product Description
- t:slim X2 Control-IQ System Integrated with Dexcom G7 CGM - Product Status
- t:slim X2 Control-IQ System Integrated with Dexcom G7 CGM - Product Description
- t:slim X3 Insulin Pump - Product Status
- t:slim X3 Insulin Pump - Product Description
- Tandem Mobi Insulin Pump With Interoperable Technology - Product Status
- Tandem Mobi Insulin Pump With Interoperable Technology - Product Description
- Tandem Mobi: Tubeless - Product Status
- Tandem Mobi: Tubeless - Product Description
- Tandem Patch - Product Status
- Tandem Patch - Product Description
- Tandem Diabetes Care Inc, Key Employees
- Tandem Diabetes Care Inc, Other Locations
- Tandem Diabetes Care Inc, Subsidiaries
- Glossary
- Tandem Diabetes Care Inc Pipeline Products by Equipment Type
- Tandem Diabetes Care Inc Pipeline Products by Development Stage
- Tandem Diabetes Care Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Insulet Corp
- DexCom Inc
- Solara Medical Supplies, Inc.
- Medtronic MiniMed Inc
- Eli Lilly and Co
